Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1050)
  3. Book Section (64)
  4. Review (63)
  5. Editorial (38)
  6. Research Letter (37)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2687)
  2. Department of Medicine (2687)
  3. Hematologic Malignancies, Division of (2687)
  4. Population Sciences Research Program (741)
  5. Survivorship Research (651)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (663)
  3. Maria Palomba (440)
  4. Ariela Noy (368)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (34)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (875)
  2. Journal of Clinical Oncology (275)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (80)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (940)
  2. American Society of Clinical Oncology (291)
  3. Elsevier Inc. (186)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2687)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Practice patterns inform patient-centered approaches for the integration of BTK inhibitors in frontline mantle cell lymphoma
    Meeting Abstract

    Graham, T.; Ackbarali, T.; Kumar, A.; Matasar, M.
    Blood (2024)

    Fulltext@MSK | Save
  • Characterization of skin response in patients with mycosis fungoides and sezary syndrome treated with mogamulizumab: A retrospective, real world cohort
    Meeting Abstract

    Christensen, R.; Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S.; Johnson, W. T.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of novel therapies (NTs) on real-world (RW) clinical outcomes of patients (pts) with relapsed/refractory (RR) mantle-cell lymphoma (MCL) by race/ethnicity and TP53 mutation status
    Meeting Abstract

    Phillips, T. J.; Danilov, A. V.; Ruan, J.; Patel, K.; Kumar, A.; Wang, Y. C.; Maglinte, G. A.; Seymour, E.; Kamdar, M.
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of the diagnosis-to-treatment interval (DTI) on outcomes in older adults with diffuse large B-cell lymphoma (DLBCL) treated in the real-world setting
    Meeting Abstract

    Hamlin, P. A.; Torka, P.; Hansen, E.; Belli, A. J.; Ambrose, J.; Zettler, C. M.; Fernandes, L. L.; Wiley, S.; Perry, B.; Wang, C. K.
    Blood (2024)

    Fulltext@MSK | Save
  • Prediction of clinical response by phased variants in circulating tumor DNA (ctDNA) in the VALENTINE-PTCL01 trial of patients with relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Mehta-Shah, N.; Horwitz, S.; Zinzani, P. L.; Barta, S. K.; Yamagishi, M.; Kurtz, D. M.; Takayama, G.; Hizukuri, Y.; Feng, W.; Chang, K. C. N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Molecular features are associated with disease stage in diffuse large B-cell lymphoma and reveal heterogeneity in patient outcomes
    Meeting Abstract

    Uppal, M.; Gurumurthi, A.; Hamlin, P. A.; Falchi, L.; Horwitz, S.; Kumar, A.; Noy, A.; Lue, J. K.; Torka, P.; Arcila, M. E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma: Final results from the phase 2 PRIMO trial
    Meeting Abstract

    Mehta-Shah, N.; Zinzani, P. L.; Jacobsen, E. D.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter-Brown, L. C.; Izutsu, K.; Bentur, O. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save